oxotremorine has been researched along with Coronary Disease in 3 studies
Oxotremorine: A non-hydrolyzed muscarinic agonist used as a research tool.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MAASSEN, JH | 1 |
| FIEGEL, G | 1 |
| KELLING, HW | 1 |
| BARGHEER, R | 1 |
| KUKWA, D | 1 |
| De Ferrari, GM | 1 |
| Vanoli, E | 1 |
| Curcuruto, P | 1 |
| Tommasini, G | 1 |
| Schwartz, PJ | 1 |
3 other studies available for oxotremorine and Coronary Disease
| Article | Year |
|---|---|
[On the treatment of coronary heart disease with a selective, long-acting substance, 3-(2-diethylaminoethyl)-4-methyl-7-carbethoxymethoxy-2-oxo-1,2-chromene].
Topics: Benzopyrans; Coronary Artery Disease; Coronary Disease; Humans; Oxotremorine; Vasodilator Agents | 1963 |
[Protracted coronary vasodilator effect of 3-(2-diethylaminoethyl)-4-methyl-7-carbethoxy-methoxy-2-oxo-1.2-chromene].
Topics: Benzopyrans; Coronary Disease; Humans; Oxotremorine; Vasodilator Agents | 1963 |
Prevention of life-threatening arrhythmias by pharmacologic stimulation of the muscarinic receptors with oxotremorine.
Topics: Animals; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Cats; Coronary Disease; Death, Su | 1992 |